https://www.selleckchem.com/pr....oducts/ZM-447439.htm
s an established empirical basis for use, demonstrating a reduction in both postoperative pain and LOS. This novel use of ERAS in a podiatric surgery outpatient population has similar findings but was not sustained in all audit criteria. PEP demonstrated promising reductions in postoperative pain and LOS; however, further implementation replication is needed to confirm this expansion of ERAS and the promising results. The use of ERAS in orthopedic patients has an established empirical basis for use, demonstrating a reduction in both p
Gefällt mir
Kommentar
Teilen
